Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 3 boards, counting each seat separately. Longest: Alnylam Pharmaceuticals Inc., 3 years.
Alnylam Pharmaceuticals Inc.
Director
Immunic Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +11,250 | $70.20 | $789,750 |
| Aug 18, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −11,250 | $450.00 | $5,062,500 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +11,250 | $131.21 | $1,476,113 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −549 | $267.14 | $146,660 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −729 | $268.56 | $195,780 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −245 | $269.79 | $66,099 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −431 | $271.68 | $117,094 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −660 | $273.16 | $180,286 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −882 | $273.75 | $241,448 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −301 | $275.63 | $82,965 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,263 | $277.16 | $350,053 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,239 | $278.01 | $344,454 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −432 | $280.03 | $120,973 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −372 | $281.10 | $104,569 |
| May 15, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −802 | $282.03 | $226,188 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.